Prime Medicine, Inc. (PRME:NASDAQ) closed at $3.67 on October 23, 2026, down 1.61% on the day. The stock trades 33.9% below its 52-week high of $5.55 and 37.5% above its 52-week low of $2.67. Over the past year, it lost 31.1%. Prime Medicine, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, PRME closed higher on 111 days (44%). Its best day was January 22, 2026 (+16.58%) and its worst was June 5, 2026 (-11.82%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 5 times.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs.
Find more stocks like PRME with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.